Delivery Order SPE2DB20D1109-SPE2DB25FP71T
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,418.48 on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 6, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,856.40 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, firm fixed-price contract was executed on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a child order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $2,067.94 to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector (2-pack) with a completion date of July 30, 2025. This competitive award, using firm fixed-price pricing with no set-aside designation, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The company, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $11,516.02 for 4,569,192,958 units of Epinephrine 0.3 mg auto-injectors (2-pack configuration). This firm fixed-price delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX). The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a $1,590.48 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector kits (2-pack configuration) with a completion date of July 23, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $2,678.32. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This award represents a child contract action under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $2,729.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,967.90 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order with an ultimate completion date of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,436.61 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This contract represents a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and was competitively awarded without any set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP71TDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,972.79 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack units). The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical devices to support military and veteran healthcare systems. The epinephrine auto-injectors delivered under this contract are essential emergency medical supplies used across Defense Health Agency, U.S. Coast Guard, and other government healthcare facilities. This transaction exemplifies the company's role within the DLA's Pharmaceutical Prime Vendor Global Program, which leverages multiple contractors to supply medical commodities worldwide and ensure continuity of critical medications and emergency medical devices throughout the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/9/25 |